Alumis Inc. ALMS
Set alert
6.73 USD -0.16 -2.32%
At close
6.78 +0.05 +0.74%
Pre-market · Nov 2, 4:00 AM ET
6.46 Day range 6.92
4.39 52-week range 31.35
- YTD
- -31.05%
- 1 year
- +44.42%
- Open
- 6.84
- Prev close
- 6.89
- Mkt cap
- 871.10M
- Vol
- 2.24M
- Avg vol
- 2.67M
- EPS
- -3.86
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 6.46
- High
- 6.92
- Forward P/E
- -2.82
- Beta
- -0.79
- Short ratio
- 6.42
- Inst. own
- 93.53%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 12, 2026
- 50-d avg
- 21.50
- 200-d avg
- 22.28
- 1y target
- 32.13
News
-
3 weeks ago benzinga.com
Alumis New Phase 3 ONWARD Data Show Envudeucitinib Improved Scalp, Itch And Quality Of Life In Psoriasis, Building On 54% PASI 100 At Week 48; NDA On Track For 4Q 2026
– Results build on ONWARD3 highest complete skin clearance (54% PASI 100) at Week 48, reinforcing envudeucitinib’s potential to become a leading oral therapy for moderate-to-severe plaque psoriasis–…